Gene · 3624
Papers2,354
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,354
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploration of effective biomarkers and infiltrating immune cells in metastatic colorectal cancer based on bioinformatics analysis. | Sci Rep | 2025 | 41006647 | PubTator, text mining | PubMed |
| Hypoxia and Multilineage Communication in 3D Organoids for Human Disease Modeling. | Biomimetics (Basel) | 2025 | 41002858 | PubTator, text mining | PubMed |
| Identification and verification of hub biomarkers and immune-related pathways participating in the trabecular meshwork after using corticosteroid. | PLoS One | 2025 | 40996982 | PubTator, text mining | PubMed |
| scKAN: interpretable single-cell analysis for cell-type-specific gene discovery and drug repurposing via Kolmogorov-Arnold networks. | Genome Biol | 2025 | 40993718 | PubTator, text mining | PubMed |
| The m6A modification in cancer: roles, implications, and its potential in therapy. | Mol Biomed | 2025 | 40986143 | PubTator, text mining | PubMed |
| Understanding Preeclampsia: Cardiovascular Pathophysiology, Histopathological Insights and Molecular Biomarkers. | Med Sci (Basel) | 2025 | 40981151 | PubTator, text mining | PubMed |
| Transcriptomic and lipidomic profiling provide novel insight into the pathogenesis of monogenic SGMS2-related osteoporosis. | JBMR Plus | 2025 | 40978119 | PubTator, text mining | PubMed |
| Based on disulfide accumulation, leveraging a THBS1-signature to improve the outcome of head and neck carcinoma patients. | Int J Biol Macromol | 2025 | 40962096 | PubTator, text mining | PubMed |
| Identification of potential hub genes and molecular mechanisms in breast cancer microenvironment: A comprehensive transcriptomics approach. | Medicine (Baltimore) | 2025 | 40898538 | PubTator, text mining | PubMed |
| A predictive model for evaluating the efficacy of immunotherapy in non-small-cell lung cancer patients: A real-world study. | J Int Med Res | 2025 | 40891808 | PubTator, text mining | PubMed |
| Defining the cell and molecular origins of the primate ovarian reserve. | Nat Commun | 2025 | 40858568 | PubTator, text mining | PubMed |
| Microbiota-derived corisin accelerates kidney fibrosis by promoting cellular aging. | Nat Commun | 2025 | 40855053 | PubTator, text mining | PubMed |
| Mixed effect gradient boosting for high-dimensional longitudinal data. | Sci Rep | 2025 | 40847064 | PubTator, text mining | PubMed |
| Integrative machine learning models predict prostate cancer diagnosis and biochemical recurrence risk: Advancing precision oncology. | NPJ Digit Med | 2025 | 40819002 | PubTator, text mining | PubMed |
| The states of senescent cells. | Biochem Soc Trans | 2025 | 40758278 | PubTator, text mining | PubMed |
| Network analysis of master regulators associated with invasive phenotypes in multiple myeloma. | Front Cell Dev Biol | 2025 | 40741330 | PubTator, text mining | PubMed |
| Identification of a stromal immunosuppressive barrier orchestrated by SPP1+/C1QC+ macrophages and CD8+ exhausted T cells driving gastric cancer immunotherapy resistance. | Front Immunol | 2025 | 40740771 | PubTator, text mining | PubMed |
| Identification of prognosis and therapy related intratumoral microbiome and immune signatures in gastric cancer. | Front Immunol | 2025 | 40677704 | PubTator, text mining | PubMed |
| Genetic variants linked to type 2 diabetes in CDKN1B and TCF7L2 influence survival outcomes in metastatic colorectal cancer. | Int J Cancer | 2025 | 40658092 | PubTator, text mining | PubMed |
| O-prenylchalcones inhibit cell proliferation and activate apoptosis by inducing mitochondrial dysfunction in gastric cancer cells. | Discov Oncol | 2025 | 40632372 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3624/papers?page=5